INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined mushrooms. Clear

An expert overview of the literature, useful as background reading.

4 studies

2020 / Narrative review

A review examined the therapeutic potential, mechanisms, efficacy, and safety of four medicinal plants in cardiovascular disease management.

This review evaluates the ethnopharmacological therapeutic potential, mechanisms, efficacy, and safety of Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum for cardiovascular diseases. It synthesizes findings from in vitro, in vivo, and clinical trial studies covering conditions such as hypertension, coronary heart disease, myocardial infarction, cardiomyopathies, peripheral vascular diseases, and dyslipidemias. The authors emphasize that while these herbs demonstrate therapeutic promise against CVD risk factors, their claimed safety requires proper testing due to potential toxicity, adverse effects, and herb-drug interactions.

Shaito A, Thuan DTB, Phu HT, et al. Front Pharmacol, 2020. PMID 32317975

2016 / Narrative review

A review indicates no scientific evidence currently supports the effectiveness of dried mushrooms or mushroom extracts in treating human disease.

This review evaluates the therapeutic use of dried mushrooms and mushroom extracts, noting their longstanding presence in traditional Chinese medicine. It reports that there is currently no scientific evidence supporting the effectiveness of these preparations in treating human disease. The author highlights concerns regarding the potential harm of these products and urges critical evaluation of commercial claims. Controlled experiments and clinical trials are needed to explore useful secondary metabolites and develop this pharmacopeia.

Money NP Fungal Biol, 2016. PMID 27020147

2013 / Narrative review

Evaluating white vegetables solely by glycemic index is context-dependent and may provide misleading dietary guidance.

This review evaluates the effect of white vegetable consumption (such as potatoes, cauliflowers, turnips, onions, parsnips, white corn, kohlrabi, and mushrooms) on glycemia, satiety, and food intake. The author notes that white vegetables vary widely in their contribution to energy, nutrient content, glycemia, and satiety. Using the potato as an example, the glycemic index can be misleading if not interpreted within the context of total dietary carbohydrate, nutrient composition, and satiety effects in typical meals. The review concludes that applying the glycemic index in isolation to judge white vegetables has led to premature and potentially counterproductive dietary guidance.

Anderson GH, Soeandy CD, Smith CE Adv Nutr, 2013. PMID 23674805

2006 / Narrative review of systematic reviews and clinical experiments

A review examined the biomedical effects of dietary fiber beta-glucan from sources like barley, oats, yeast, and mushrooms.

Beta-glucan is a polysaccharide fiber found in grains such as barley, oats, yeast, and mushrooms. The authors reviewed systematic reviews and clinical experiments evaluating the biomedical effects of beta-glucan, including lipid lowering, blood sugar reduction, weight reduction, immune modulation, and anticarcinogenic effects. The review aimed to identify issues and help develop future research strategies.

Kim SY, Song HJ, Lee YY, et al. J Korean Med Sci, 2006. PMID 17043406